Web Analytics
crypto.news
2025-03-25 09:13:49

XRP outpaces Solana in spot trading as future launch looms

XRP’s price saw a 13% surge after the SEC dropped its case against Ripple Labs, potentially triggering optimism for future ETF approvals and a rise in market activity. Ripple Labs’ XRP ( XRP ) has recently overtaken Solana ( SOL ) in spot trading, now regularly grabbing more than 50% of the volume, a big shift from when SOL used to dominate with 70-80%. With the legal battle no longer hanging over XRP, odds of an ETF approval in 2025 have climbed on prediction markets, analysts at blockchain analytics firm Kaiko note. Polymarket data on Ripple ETF approval odds | Source: Polymarket According to data from prediction market Polymarket, the odds of a spot Ripple ETF approval in 2025 jumped 6% after the SEC dropped its case, with the market now pricing in an 83% chance that spot XRP ETFs will get the green light by the end of 2025. “The raft of activity in XRP markets doesn’t appear to be an anomaly either. Higher volumes have been matched by improved liquidity for XRP as the average 1% market depth climbed steadily — now above SOL.” Kaiko You might also like: XRP surges 4% as March options attract heavy call interest Now, with the regulatory roadblock removed, Kaiko says the market could could see product launches for XRP “in the coming months.” For instance, in January the CME released a mock webpage for SOL and XRP futures “in error,” with one of those products now launched and the second “released from its regulatory purgatory,” the firm added. Ripple CEO Brad Garlinghouse hinted earlier in March that XRP ETFs could hit the U.S. market by the second half of 2025. At least ten applications for XRP ETFs — including spot, leveraged, and inverse products—are waiting for SEC approval, with Franklin Templeton recently joining the list of applicants. Read more: Chart of the week: XRP price dips day after Ripple CEO announces SEC to drop lawsuit appeal, time to buy?

Get Crypto Newsletter
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.